CN118389625A - Method for co-producing glucosamine hydrochloride and D-psicose from fructose solution - Google Patents
Method for co-producing glucosamine hydrochloride and D-psicose from fructose solution Download PDFInfo
- Publication number
- CN118389625A CN118389625A CN202410505926.XA CN202410505926A CN118389625A CN 118389625 A CN118389625 A CN 118389625A CN 202410505926 A CN202410505926 A CN 202410505926A CN 118389625 A CN118389625 A CN 118389625A
- Authority
- CN
- China
- Prior art keywords
- psicose
- solution
- glucosamine hydrochloride
- glucosamine
- fructose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- CBOJBBMQJBVCMW-BTVCFUMJSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;hydrochloride Chemical compound Cl.O=C[C@H](N)[C@@H](O)[C@H](O)[C@H](O)CO CBOJBBMQJBVCMW-BTVCFUMJSA-N 0.000 title claims abstract description 54
- 229960001911 glucosamine hydrochloride Drugs 0.000 title claims abstract description 54
- BJHIKXHVCXFQLS-PUFIMZNGSA-N D-psicose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C(=O)CO BJHIKXHVCXFQLS-PUFIMZNGSA-N 0.000 title claims abstract description 40
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 title claims abstract description 34
- 229930091371 Fructose Natural products 0.000 title claims abstract description 33
- 239000005715 Fructose Substances 0.000 title claims abstract description 33
- 238000000034 method Methods 0.000 title claims abstract description 22
- 239000000243 solution Substances 0.000 claims abstract description 82
- 239000012528 membrane Substances 0.000 claims abstract description 77
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 51
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 29
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000000919 ceramic Substances 0.000 claims abstract description 26
- 238000001728 nano-filtration Methods 0.000 claims abstract description 26
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000003729 cation exchange resin Substances 0.000 claims abstract description 21
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims abstract description 20
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229960002442 glucosamine Drugs 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000011259 mixed solution Substances 0.000 claims abstract description 17
- 108030002106 D-psicose 3-epimerases Proteins 0.000 claims abstract description 14
- 102000004894 Glutamine-fructose-6-phosphate transaminase (isomerizing) Human genes 0.000 claims abstract description 14
- 108090001031 Glutamine-fructose-6-phosphate transaminase (isomerizing) Proteins 0.000 claims abstract description 14
- 235000019270 ammonium chloride Nutrition 0.000 claims abstract description 13
- 238000004042 decolorization Methods 0.000 claims abstract description 13
- 239000000047 product Substances 0.000 claims abstract description 13
- 239000012043 crude product Substances 0.000 claims abstract description 12
- LKDRXBCSQODPBY-JDJSBBGDSA-N D-allulose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@H]1O LKDRXBCSQODPBY-JDJSBBGDSA-N 0.000 claims abstract description 10
- 102000004190 Enzymes Human genes 0.000 claims abstract description 9
- 108090000790 Enzymes Proteins 0.000 claims abstract description 9
- 239000007788 liquid Substances 0.000 claims description 41
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 33
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 23
- 239000011148 porous material Substances 0.000 claims description 20
- 238000006243 chemical reaction Methods 0.000 claims description 18
- 238000001914 filtration Methods 0.000 claims description 15
- 239000003957 anion exchange resin Substances 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 239000007853 buffer solution Substances 0.000 claims description 12
- 239000008213 purified water Substances 0.000 claims description 12
- 239000007787 solid Substances 0.000 claims description 12
- 230000008569 process Effects 0.000 claims description 11
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 10
- 239000012510 hollow fiber Substances 0.000 claims description 9
- 238000000926 separation method Methods 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 7
- 229910019142 PO4 Inorganic materials 0.000 claims description 6
- 239000010452 phosphate Substances 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- 239000008363 phosphate buffer Substances 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 239000012295 chemical reaction liquid Substances 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 230000008929 regeneration Effects 0.000 claims 1
- 238000011069 regeneration method Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 15
- 239000000203 mixture Substances 0.000 abstract description 8
- 239000012527 feed solution Substances 0.000 abstract description 5
- 239000006227 byproduct Substances 0.000 abstract description 4
- 230000002779 inactivation Effects 0.000 abstract description 2
- 150000001768 cations Chemical class 0.000 abstract 1
- 239000011347 resin Substances 0.000 abstract 1
- 229920005989 resin Polymers 0.000 abstract 1
- 239000012141 concentrate Substances 0.000 description 11
- 239000013078 crystal Substances 0.000 description 8
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 8
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 8
- 235000019796 monopotassium phosphate Nutrition 0.000 description 8
- 239000008055 phosphate buffer solution Substances 0.000 description 8
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 238000000605 extraction Methods 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 241000238557 Decapoda Species 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 210000001179 synovial fluid Anatomy 0.000 description 2
- QKPLRMLTKYXDST-NSEZLWDYSA-N (3r,4r,5s,6r)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol;hydrochloride Chemical compound Cl.N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O QKPLRMLTKYXDST-NSEZLWDYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N 3,4,5,6-tetrahydroxyoxane-2-carboxylic acid Chemical compound OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012269 metabolic engineering Methods 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/02—Monosaccharides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
- C07H5/06—Aminosugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/02—Monosaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/24—Preparation of compounds containing saccharide radicals produced by the action of an isomerase, e.g. fructose
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Saccharide Compounds (AREA)
Abstract
本发明公开了一种从果糖溶液中联产氨基葡萄糖盐酸盐和D‑阿洛酮糖的方法,涉及阿洛酮糖生产技术领域,通过向果糖溶液加入D‑阿洛酮糖3‑差向异构酶,得到含果糖和阿洛酮糖的混合液,混合液继续加入氨基葡萄糖‑6‑磷酸合成酶和氯化铵,得到含氨基葡萄糖和阿洛酮糖的料液,然后进陶瓷膜,超滤膜,阴阳树脂柱,纳滤膜,在通过热浓缩,降温,过滤得到阿洛酮糖,然后用盐酸作为解吸剂来冲洗阳离子交换树脂柱,收集pH2‑3的解吸液,浓缩,降温过滤得到氨基葡萄糖盐酸盐粗品,粗品加水溶解,脱色,降温过滤得到氨基葡萄糖盐酸盐成品。节约了时间和经济成本,不需要酶的灭酶和多级脱色,产品纯度高,副产物少。
The invention discloses a method for co-producing glucosamine hydrochloride and D-psicose from a fructose solution, and relates to the technical field of psicose production, wherein D-psicose 3-epimerase is added to the fructose solution to obtain a mixed solution containing fructose and psicose, and the mixed solution is further added with glucosamine-6-phosphate synthase and ammonium chloride to obtain a feed solution containing glucosamine and psicose, and then a ceramic membrane, an ultrafiltration membrane, a cation resin column, and a nanofiltration membrane are introduced, and then the mixture is concentrated by heat, cooled, and filtered to obtain psicose, and then hydrochloric acid is used as a desorbent to rinse the cation exchange resin column, and a desorbent with a pH of 2-3 is collected, concentrated, cooled, and filtered to obtain a crude glucosamine hydrochloride product, and the crude product is dissolved in water, decolorized, and cooled and filtered to obtain a finished glucosamine hydrochloride product. Time and economic costs are saved, enzyme inactivation and multi-stage decolorization are not required, and the product purity is high and there are few by-products.
Description
技术领域Technical Field
本发明涉及阿洛酮糖生产技术领域,具体涉及一种从果糖溶液中联产氨基葡萄糖盐酸盐和D-阿洛酮糖的方法。The invention relates to the technical field of psicose production, and in particular to a method for co-producing glucosamine hydrochloride and D-psicose from a fructose solution.
背景技术Background technique
D-阿洛酮糖是一种非常重要的稀有己酮糖,甜度为蔗糖的70%,但是其能量几乎为0,溶剂特性与口感与蔗糖相近,并能发生美拉德反应,在食药行业D-阿洛酮糖是蔗糖的理想替代品。此外,D-阿洛酮糖具有抑制肥胖,降血糖,降血脂等功能,非常适用于糖尿病患者和肥胖人群的食用,因此在医疗、保健方面具有显著功效。目前,D-阿洛酮糖的生产主要是基于异构酶催化D-果糖的异构化反应,该反应是一个可逆反应,存在转化率低的问题,转化率在30%左右。D-psicose is a very important rare ketohexose with a sweetness of 70% of sucrose, but almost zero energy. Its solvent properties and taste are similar to those of sucrose, and it can undergo the Maillard reaction. In the food and drug industry, D-psicose is an ideal substitute for sucrose. In addition, D-psicose has the functions of inhibiting obesity, lowering blood sugar, and lowering blood lipids. It is very suitable for consumption by diabetic patients and obese people, so it has significant effects in medical treatment and health care. At present, the production of D-psicose is mainly based on the isomerization reaction of D-fructose catalyzed by isomerase. This reaction is a reversible reaction with a low conversion rate of about 30%.
氨基葡萄糖盐酸盐又名2-氨基-2-脱氧-葡萄糖盐酸盐,其分子式为C6H13NO5.HCl。氨基葡萄糖在人体内可通过刺激粘多糖合成及增加骨骼钙质的摄取量,改善及增强滑膜液的粘稠度,增加滑膜液合成,从而提高关节润滑功能,有助于改善关节活动功能,缓解关节疼痛。目前,国内外氨基葡萄糖盐酸盐的传统生产方法有生物提取法和化学合成法两种,其中生物提取法为主要生产方法。生物提取法是指先从虾蟹壳中提取甲壳素或壳聚糖,再经盐酸水解而成氨基葡萄糖盐酸盐。该生产方法的缺陷主要包括:第一、来自水产品壳提取的氨基葡萄糖盐酸盐对水产品过敏反应的患者不适用;第二、纯化工艺复杂,产品有鱼腥味,不稳定;第三、受环境污染影响,从虾蟹壳中提取氨基葡萄糖盐酸盐,不可避免地受到重金属污染。相比较而言,生物提取法中的微生物发酵法生产氨基葡萄糖盐酸盐是一条更好的工艺路线,且微生物发酵法生产的产品无鱼腥味,生产资源不受限制;利用代谢工程进行菌种改良,可得到产量极高的工程菌,具有工业化大生产的潜力。但微生物代谢途径的遗传改造难度较高,且存在工程菌株遗传稳定性难以控制、易产生代谢副产物等缺点,影响工业应用及增加了生产成本。Glucosamine hydrochloride is also known as 2-amino-2-deoxy-glucose hydrochloride, and its molecular formula is C 6 H 13 NO 5 .HCl. Glucosamine can stimulate mucopolysaccharide synthesis and increase the intake of bone calcium in the human body, improve and enhance the viscosity of synovial fluid, increase synovial fluid synthesis, thereby improving joint lubrication function, helping to improve joint mobility and relieve joint pain. At present, the traditional production methods of glucosamine hydrochloride at home and abroad include biological extraction and chemical synthesis, among which biological extraction is the main production method. The biological extraction method refers to first extracting chitin or chitosan from shrimp and crab shells, and then hydrolyzing it with hydrochloric acid to form glucosamine hydrochloride. The defects of this production method mainly include: first, glucosamine hydrochloride extracted from aquatic product shells is not suitable for patients with allergic reactions to aquatic products; second, the purification process is complicated, the product has a fishy smell and is unstable; third, affected by environmental pollution, glucosamine hydrochloride extracted from shrimp and crab shells is inevitably contaminated by heavy metals. In comparison, the production of glucosamine hydrochloride by microbial fermentation in the biological extraction method is a better process route, and the products produced by the microbial fermentation method have no fishy smell and are not limited by production resources; the use of metabolic engineering to improve strains can obtain engineered bacteria with extremely high yields, which have the potential for large-scale industrial production. However, the genetic modification of microbial metabolic pathways is difficult, and there are disadvantages such as the difficulty in controlling the genetic stability of engineered strains and the easy production of metabolic byproducts, which affects industrial applications and increases production costs.
发明内容Summary of the invention
本发明所要解决的技术问题是:针对现有技术存在的不足,提供一种从果糖溶液中联产氨基葡萄糖盐酸盐和D-阿洛酮糖的方法,产品纯度高,副产物少。The technical problem to be solved by the present invention is: in view of the shortcomings of the prior art, a method for co-producing glucosamine hydrochloride and D-psicose from a fructose solution is provided, wherein the product has high purity and few by-products.
为解决上述技术问题,本发明的技术方案是:In order to solve the above technical problems, the technical solution of the present invention is:
一种从果糖溶液中联产氨基葡萄糖盐酸盐和D-阿洛酮糖的方法,包括以下步骤:A method for co-producing glucosamine hydrochloride and D-psicose from a fructose solution comprises the following steps:
A:果糖溶液中加入D-阿洛酮糖3-差向异构酶,然后加入第一缓冲溶液调节体系pH至6-8,在30-40℃下反应4-10h,得反应液;A: D-psicose 3-epimerase is added to the fructose solution, and then the first buffer solution is added to adjust the pH of the system to 6-8, and the reaction is carried out at 30-40° C. for 4-10 hours to obtain a reaction solution;
B:反应液进中空纤维膜分离,实现酶和混合液的分离;B: The reaction solution enters the hollow fiber membrane for separation to achieve separation of the enzyme and the mixed solution;
C:向混合液中加入氨基葡萄糖-6-磷酸合成酶和氯化铵,混合均匀,然后加入第二缓冲溶液调节体系pH至6.5-7.5,在30-50℃下反应8-14h,得含氨基葡萄糖和D-阿洛酮糖的料液;C: adding glucosamine-6-phosphate synthase and ammonium chloride to the mixed solution, mixing evenly, then adding the second buffer solution to adjust the pH of the system to 6.5-7.5, reacting at 30-50° C. for 8-14 hours, and obtaining a feed solution containing glucosamine and D-psicose;
D:将含氨基葡萄糖和阿洛酮糖的料液经陶瓷膜过滤,收集陶瓷膜清液;D: filtering the liquid containing glucosamine and allulose through a ceramic membrane, and collecting the ceramic membrane clear liquid;
E:将陶瓷膜清液过超滤膜,收集超滤膜清液;E: passing the ceramic membrane clear liquid through the ultrafiltration membrane and collecting the ultrafiltration membrane clear liquid;
F:将收集的超滤膜清液进阳离子交换树脂柱,收集的第一流出液进阴离子交换树脂柱,收集得到第二流出液;F: The collected ultrafiltration membrane clear liquid is fed into a cation exchange resin column, and the collected first effluent is fed into an anion exchange resin column to collect a second effluent;
G:将第二流出液经纳滤膜过滤,收集纳滤浓液;G: filtering the second effluent through a nanofiltration membrane and collecting the nanofiltration concentrate;
H:将纳滤浓液在温度50-70℃,真空度<-0.090Mpa的条件下浓缩至固含70-80%w/w,然后降温至10-15℃,抽滤,用乙醇进行洗涤,抽滤,得D-阿洛酮糖;H: Concentrating the nanofiltrate concentrate to a solid content of 70-80% w/w at a temperature of 50-70° C. and a vacuum degree of <-0.090 MPa, then cooling to 10-15° C., filtering with suction, washing with ethanol, and filtering with suction to obtain D-psicose;
I:然后用盐酸溶液进步骤F中的阳离子交换树脂柱,收集pH 2-3的流出液,浓缩至固含量为70-90%w/w,然后以1-5℃/h的速度降温至20-25℃,过滤后得到氨基葡萄糖盐酸盐粗品。I: Then, the hydrochloric acid solution is passed through the cation exchange resin column in step F, and the effluent at pH 2-3 is collected and concentrated to a solid content of 70-90% w/w, and then cooled to 20-25°C at a rate of 1-5°C/h, and filtered to obtain a crude product of glucosamine hydrochloride.
优选的,所述果糖溶液的浓度为50-100g/L,所述D-阿洛酮糖3-差向异构酶的加入量为10-30U/mL,所述氨基葡萄糖-6-磷酸合成酶的加入量为30-50U/mL。Preferably, the concentration of the fructose solution is 50-100 g/L, the amount of D-psicose 3-epimerase added is 10-30 U/mL, and the amount of glucosamine-6-phosphate synthase added is 30-50 U/mL.
优选的,所述第一缓冲液和所述第二缓冲液均为磷酸盐缓冲溶液,所述第一缓冲液和所述第二缓冲液的浓度均为50-100mmol/L。Preferably, the first buffer solution and the second buffer solution are both phosphate buffer solutions, and the concentrations of the first buffer solution and the second buffer solution are both 50-100 mmol/L.
优选的,所述中空纤维膜的进料流速为30-40mL/min。Preferably, the feed flow rate of the hollow fiber membrane is 30-40 mL/min.
优选的,所述氯化铵的加入量占混合液体积的200-800mmol/L。Preferably, the amount of ammonium chloride added is 200-800 mmol/L of the volume of the mixed solution.
优选的,所述陶瓷膜的孔径范围为20-100nm,所述超滤膜的孔径范围为5000-10000Da,所述纳滤膜的孔径范围为150-300Da。Preferably, the pore size range of the ceramic membrane is 20-100 nm, the pore size range of the ultrafiltration membrane is 5000-10000 Da, and the pore size range of the nanofiltration membrane is 150-300 Da.
优选的,步骤F中所述阳离子交换树脂柱的进料流速为1-5BV/h,所述阴离子交换树脂柱的进料流速为0.5-1.5BV/h;Preferably, in step F, the feed flow rate of the cation exchange resin column is 1-5 BV/h, and the feed flow rate of the anion exchange resin column is 0.5-1.5 BV/h;
步骤I中盐酸溶液的浓度为0.1-0.5mol/L,加入量为阳离子交换树脂柱体积的2-3倍,流速为0.5-1.5BV/h;The concentration of the hydrochloric acid solution in step I is 0.1-0.5 mol/L, the amount added is 2-3 times the volume of the cation exchange resin column, and the flow rate is 0.5-1.5 BV/h;
所述阴离子交换树脂柱加入氢氧化钠溶液进行再生。The anion exchange resin column is regenerated by adding sodium hydroxide solution.
优选的,步骤I中收集pH小于2的流出液,用于盐酸溶液的配制;Preferably, in step I, the effluent with a pH value less than 2 is collected and used for preparing the hydrochloric acid solution;
步骤G中的纳滤清液用于盐酸溶液和氢氧化钠溶液的配制。The nanofiltration clear liquid in step G is used for the preparation of hydrochloric acid solution and sodium hydroxide solution.
优选的,将氨基葡萄糖盐酸盐粗品中加入纯水,进行搅拌,升温至粗品溶解,加入活性炭进行脱色,然后降温,过滤,洗涤,干燥得到氨基葡萄糖磷酸盐成品。Preferably, pure water is added to the crude glucosamine hydrochloride, stirred, heated until the crude product is dissolved, activated carbon is added for decolorization, then cooled, filtered, washed, and dried to obtain the finished glucosamine phosphate.
优选的,纯化水的加入量为氨基葡萄糖盐酸盐粗品重量的1-3倍,加入纯化水后的搅拌转速为50-150r/min,加热溶解温度为50-80℃;Preferably, the amount of purified water added is 1-3 times the weight of the crude glucosamine hydrochloride, the stirring speed after adding purified water is 50-150r/min, and the heating and dissolving temperature is 50-80°C;
所述活性炭的加入量占氨基葡萄糖盐酸盐粗品重量的1-5%w/w,脱色后降温至20-25℃。The amount of activated carbon added is 1-5% w/w of the weight of the crude glucosamine hydrochloride, and the temperature is lowered to 20-25° C. after decolorization.
由于采用了上述技术方案,本发明的有益效果是:Due to the adoption of the above technical solution, the beneficial effects of the present invention are:
1、通过中空纤维膜和陶瓷膜实现了酶与料液的分离,不需要模拟移动床,提高了分离效率,节约了生产成本。1. The enzyme and the liquid are separated by hollow fiber membrane and ceramic membrane, without the need for simulated moving bed, which improves the separation efficiency and saves production costs.
2、通过D-阿洛酮糖3-差向异构酶和氨基葡萄糖-6-磷酸合成酶,果糖的转化更加彻底,提高了果糖的利用率,避免原料的浪费,提高了产品的收率。2. Through D-psicose 3-epimerase and glucosamine-6-phosphate synthase, the conversion of fructose is more thorough, which improves the utilization rate of fructose, avoids the waste of raw materials, and improves the yield of the product.
3、通过对D-阿洛酮糖和氨基葡萄糖盐酸盐进行联产,节约了时间和生产成本,提高了企业的经济效益。3. By co-producing D-psicose and glucosamine hydrochloride, time and production costs are saved and the economic benefits of the enterprise are improved.
4、不需要酶的灭酶和多级脱色,简化了生产步骤,工艺更加简单。4. No enzyme inactivation and multi-stage decolorization are required, which simplifies the production steps and makes the process simpler.
5、得到的氨基葡萄糖盐酸盐和D-阿洛酮糖产品纯度高,副产物少。5. The obtained glucosamine hydrochloride and D-psicose products have high purity and few by-products.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1是本发明实施例3中氨基葡萄糖盐酸盐的液相色谱图;Fig. 1 is a liquid chromatogram of glucosamine hydrochloride in Example 3 of the present invention;
图2是本发明实施例3中D-阿洛酮糖的液相色谱图。FIG. 2 is a liquid chromatogram of D-psicose in Example 3 of the present invention.
具体实施方式Detailed ways
下面结合实施例,进一步阐述本发明。The present invention will be further described below in conjunction with the embodiments.
实施例1Example 1
一种从果糖溶液中联产氨基葡萄糖盐酸盐和D-阿洛酮糖的方法,包括以下步骤:A method for co-producing glucosamine hydrochloride and D-psicose from a fructose solution comprises the following steps:
A:50g/L的果糖溶液(50L)中加入D-阿洛酮糖3-差向异构酶,然后加入浓度为50mmol/L的磷酸盐缓冲溶液(磷酸氢二钾的浓度为8.71g/L,磷酸二氢钾的浓度为0.68g/L)调节体系pH至6,在30℃下反应10h,得反应液(52.0L),其中所述D-阿洛酮糖3-差向异构酶的加入量为10U/mL;A: D-psicose 3-epimerase was added to a 50 g/L fructose solution (50 L), and then a 50 mmol/L phosphate buffer solution (the concentration of dipotassium hydrogen phosphate was 8.71 g/L, and the concentration of potassium dihydrogen phosphate was 0.68 g/L) was added to adjust the pH of the system to 6, and the mixture was reacted at 30° C. for 10 h to obtain a reaction solution (52.0 L), wherein the amount of D-psicose 3-epimerase added was 10 U/mL;
B:反应液以30mL/min的流速进中空纤维膜分离,实现酶和混合液(55.0L)的分离;B: The reaction solution was separated by hollow fiber membrane at a flow rate of 30 mL/min to achieve separation of enzyme and mixed solution (55.0 L);
C:向混合液中加入氨基葡萄糖-6-磷酸合成酶和氯化铵,混合均匀,然后加入浓度为50mmol/L的磷酸盐缓冲溶液(磷酸氢二钾的浓度为8.71g/L,磷酸二氢钾的浓度为0.68g/L)调节体系pH至6.5,在30℃下反应14h,得含氨基葡萄糖和D-阿洛酮糖的料液(64.0L),其中,所述氨基葡萄糖-6-磷酸合成酶的加入量为30U/mL,所述氯化铵的加入量占混合液体积的200mmol/L;C: Add glucosamine-6-phosphate synthase and ammonium chloride to the mixed solution, mix well, then add 50 mmol/L phosphate buffer solution (the concentration of dipotassium hydrogen phosphate is 8.71 g/L, the concentration of potassium dihydrogen phosphate is 0.68 g/L) to adjust the pH of the system to 6.5, react at 30°C for 14 hours, and obtain a feed solution (64.0 L) containing glucosamine and D-psicose, wherein the amount of glucosamine-6-phosphate synthase added is 30 U/mL, and the amount of ammonium chloride added accounts for 200 mmol/L of the volume of the mixed solution;
D:将含氨基葡萄糖和阿洛酮糖的料液经陶瓷膜过滤,收集陶瓷膜清液(68.0L),所述陶瓷膜的孔径范围为100nm;D: filtering the slurry containing glucosamine and psicose through a ceramic membrane, and collecting the ceramic membrane clear liquid (68.0 L), wherein the pore size range of the ceramic membrane is 100 nm;
E:将陶瓷膜清液过超滤膜,收集超滤膜清液(76.0L),所述超滤膜的孔径范围为10000Da;E: passing the ceramic membrane clear liquid through an ultrafiltration membrane, and collecting the ultrafiltration membrane clear liquid (76.0 L), wherein the pore size range of the ultrafiltration membrane is 10000 Da;
F:将收集的超滤膜清液以1BV/h的流速进阳离子交换树脂柱,收集的第一流出液(96.0L)以0.5BV/h的流速进阴离子交换树脂柱,收集得到第二流出液(116.0L);F: The collected ultrafiltration membrane clear liquid is fed into a cation exchange resin column at a flow rate of 1 BV/h, and the collected first effluent (96.0 L) is fed into an anion exchange resin column at a flow rate of 0.5 BV/h to collect a second effluent (116.0 L);
G:将第二流出液经纳滤膜过滤,收集纳滤浓液(13.5L),所述纳滤膜的孔径范围为300Da,纳滤清液(86.5L)用于盐酸溶液和氢氧化钠溶液的配制;G: filtering the second effluent through a nanofiltration membrane, collecting the nanofiltration concentrate (13.5 L), wherein the pore size range of the nanofiltration membrane is 300 Da, and the nanofiltration clear solution (86.5 L) is used for the preparation of hydrochloric acid solution and sodium hydroxide solution;
H:将纳滤浓液在温度50℃,真空度<-0.090Mpa的条件下浓缩至固含70%w/w,然后降温至10℃,抽滤,用乙醇进行洗涤,抽滤,得D-阿洛酮糖(638.0g),收率为85.1%,纯度为99.3%,晶体颜色为白色;H: The nanofiltrate concentrate was concentrated to a solid content of 70% w/w at a temperature of 50° C. and a vacuum degree of <-0.090 MPa, then cooled to 10° C., filtered, washed with ethanol, and filtered to obtain D-psicose (638.0 g) with a yield of 85.1% and a purity of 99.3%. The crystal color was white;
I:然后用0.1mol/L的盐酸溶液以0.5BV/h的流速进步骤F中的阳离子交换树脂柱,盐酸溶液的进料量为阳离子交换树脂柱体积的2倍。收集pH小于2的流出液(14L),用于盐酸溶液的配制,收集pH 2-3的流出液(30L),浓缩至固含量为70%w/w,然后以5℃/h的速度降温至25℃,过滤后得到氨基葡萄糖盐酸盐粗品(1513g)。I: Then, 0.1 mol/L hydrochloric acid solution was fed into the cation exchange resin column in step F at a flow rate of 0.5 BV/h, and the feed amount of the hydrochloric acid solution was twice the volume of the cation exchange resin column. The effluent (14 L) with a pH value less than 2 was collected and used for the preparation of the hydrochloric acid solution, and the effluent (30 L) with a pH value of 2-3 was collected and concentrated to a solid content of 70% w/w, and then cooled to 25°C at a rate of 5°C/h, and filtered to obtain a crude glucosamine hydrochloride product (1513 g).
将氨基葡萄糖盐酸盐粗品中加入纯水,进行搅拌,升温至粗品溶解(6.5L),加入活性炭进行脱色,然后降温,过滤,洗涤,干燥得到氨基葡萄糖磷酸盐成品(1301g),收率为86.0%,纯度为99.1%,晶体颜色为白色。Pure water was added to the crude glucosamine hydrochloride, stirred, and heated until the crude product was dissolved (6.5 L). Activated carbon was added for decolorization, and then cooled, filtered, washed, and dried to obtain the finished glucosamine phosphate (1301 g) with a yield of 86.0%, a purity of 99.1%, and white crystal color.
纯化水的加入量为氨基葡萄糖盐酸盐粗品重量的3倍,加入纯化水后的搅拌转速为50r/min,加热溶解温度为50℃;The amount of purified water added is 3 times the weight of the crude glucosamine hydrochloride, the stirring speed after adding purified water is 50r/min, and the heating and dissolving temperature is 50°C;
所述活性炭的加入量占氨基葡萄糖盐酸盐粗品重量的1%w/w,脱色后降温至20℃。The amount of activated carbon added is 1% w/w of the weight of the crude glucosamine hydrochloride, and the temperature is lowered to 20° C. after decolorization.
所述阴离子交换树脂柱加入氢氧化钠溶液进行再生。The anion exchange resin column is regenerated by adding sodium hydroxide solution.
实施例2Example 2
一种从果糖溶液中联产氨基葡萄糖盐酸盐和D-阿洛酮糖的方法,包括以下步骤:A method for co-producing glucosamine hydrochloride and D-psicose from a fructose solution comprises the following steps:
A:100g/L的果糖溶液(50.0L)中加入D-阿洛酮糖3-差向异构酶,然后加入浓度为100mmol/L的磷酸盐缓冲溶液(磷酸氢二钾的浓度为15.66g/L,磷酸二氢钾的浓度为1.36g/L)调节体系pH至8,在40℃下反应4h,得反应液(60.0L),其中所述D-阿洛酮糖3-差向异构酶的加入量为30U/mL;A: D-psicose 3-epimerase was added to a 100 g/L fructose solution (50.0 L), and then a phosphate buffer solution with a concentration of 100 mmol/L (the concentration of dipotassium hydrogen phosphate was 15.66 g/L, and the concentration of potassium dihydrogen phosphate was 1.36 g/L) was added to adjust the pH of the system to 8, and the reaction was carried out at 40° C. for 4 h to obtain a reaction solution (60.0 L), wherein the amount of D-psicose 3-epimerase added was 30 U/mL;
B:反应液以40mL/min的流速进中空纤维膜分离,实现酶和混合液(65.0L)的分离;B: The reaction solution was separated by hollow fiber membrane at a flow rate of 40 mL/min to achieve separation of enzyme and mixed solution (65.0 L);
C:向混合液中加入氨基葡萄糖-6-磷酸合成酶和氯化铵,混合均匀,然后加入浓度为100mmol/L的磷酸盐缓冲溶液(磷酸氢二钾的浓度为15.66g/L,磷酸二氢钾的浓度为1.36g/L)调节体系pH至7.5,在50℃下反应8h,得含氨基葡萄糖和D-阿洛酮糖的料液(75.5L),其中,所述氨基葡萄糖-6-磷酸合成酶的加入量为50U/mL,所述氯化铵的加入量占混合液体积的800mmol/L;C: Add glucosamine-6-phosphate synthase and ammonium chloride to the mixed solution, mix well, then add 100 mmol/L phosphate buffer solution (the concentration of dipotassium hydrogen phosphate is 15.66 g/L, and the concentration of potassium dihydrogen phosphate is 1.36 g/L) to adjust the pH of the system to 7.5, react at 50°C for 8 hours, and obtain a feed solution (75.5 L) containing glucosamine and D-psicose, wherein the amount of glucosamine-6-phosphate synthase added is 50 U/mL, and the amount of ammonium chloride added accounts for 800 mmol/L of the volume of the mixed solution;
D:将含氨基葡萄糖和阿洛酮糖的料液经陶瓷膜过滤,收集陶瓷膜清液(86.0L),所述陶瓷膜的孔径范围为20nm;D: filtering the slurry containing glucosamine and psicose through a ceramic membrane, and collecting the ceramic membrane clear liquid (86.0 L), wherein the pore size range of the ceramic membrane is 20 nm;
E:将陶瓷膜清液过超滤膜,收集超滤膜清液(92.0L),所述超滤膜的孔径范围为5000Da;E: passing the ceramic membrane clear liquid through an ultrafiltration membrane, and collecting the ultrafiltration membrane clear liquid (92.0 L), wherein the pore size range of the ultrafiltration membrane is 5000 Da;
F:将收集的超滤膜清液以5BV/h的流速进阳离子交换树脂柱,收集的第一流出液(112L)以1.5BV/h的流速进阴离子交换树脂柱,收集得到第二流出液(132L);F: The collected ultrafiltration membrane clear liquid is fed into a cation exchange resin column at a flow rate of 5 BV/h, and the collected first effluent (112 L) is fed into an anion exchange resin column at a flow rate of 1.5 BV/h to collect a second effluent (132 L);
G:将第二流出液经纳滤膜过滤,收集纳滤浓液(17.6L),所述纳滤膜的孔径范围为150Da,纳滤清液(124.0L)用于盐酸溶液和氢氧化钠溶液的配制;G: Filter the second effluent through a nanofiltration membrane, collect the nanofiltration concentrate (17.6 L), the pore size range of the nanofiltration membrane is 150 Da, and the nanofiltration clear liquid (124.0 L) is used for the preparation of hydrochloric acid solution and sodium hydroxide solution;
H:将纳滤浓液在温度70℃,真空度<-0.090Mpa的条件下浓缩至固含80%w/w,然后降温至15℃,抽滤,用乙醇进行洗涤,抽滤,得D-阿洛酮糖(1329.5g),收率为88.6%,纯度为99.5%,晶体颜色为白色;H: The nanofiltrate concentrate was concentrated to a solid content of 80% w/w at a temperature of 70° C. and a vacuum degree of <-0.090 MPa, then cooled to 15° C., filtered, washed with ethanol, and filtered to obtain D-psicose (1329.5 g) with a yield of 88.6% and a purity of 99.5%. The crystal color was white;
I:然后用0.5mol/L的盐酸溶液以1.5BV/h的流速进步骤F中的阳离子交换树脂柱,盐酸溶液的进料量为阳离子交换树脂柱体积的3倍。收集pH小于2的流出液(16.0L),用于盐酸溶液的配制,收集pH 2-3的流出液(46.0L),浓缩至固含量为90%w/w,然后以1℃/h的速度降温至20℃,过滤后得到氨基葡萄糖盐酸盐粗品(3150g)。I: Then, 0.5 mol/L hydrochloric acid solution was fed into the cation exchange resin column in step F at a flow rate of 1.5 BV/h, and the feed amount of the hydrochloric acid solution was 3 times the volume of the cation exchange resin column. The effluent (16.0 L) with a pH value less than 2 was collected and used for the preparation of the hydrochloric acid solution, and the effluent (46.0 L) with a pH value of 2-3 was collected and concentrated to a solid content of 90% w/w, and then cooled to 20°C at a rate of 1°C/h, and filtered to obtain a crude product of glucosamine hydrochloride (3150 g).
将氨基葡萄糖盐酸盐粗品中加入纯水,进行搅拌,升温至粗品溶解(11.0L),加入活性炭进行脱色,然后降温,过滤,洗涤,干燥得到氨基葡萄糖磷酸盐成品(2914g),收率为92.5%,纯度为99.4%,晶体颜色为白色,。Add pure water to the crude glucosamine hydrochloride, stir, heat until the crude product is dissolved (11.0L), add activated carbon for decolorization, then cool, filter, wash, and dry to obtain the finished glucosamine phosphate (2914g) with a yield of 92.5%, a purity of 99.4%, and white crystal color.
纯化水的加入量为氨基葡萄糖盐酸盐粗品重量的2倍,加入纯化水后的搅拌转速为150r/min,加热溶解温度为65℃;The amount of purified water added is twice the weight of the crude glucosamine hydrochloride, the stirring speed after adding purified water is 150r/min, and the heating and dissolving temperature is 65°C;
所述活性炭的加入量占氨基葡萄糖盐酸盐粗品重量的5%w/w,脱色后降温至25℃。The amount of activated carbon added is 5% w/w of the weight of the crude glucosamine hydrochloride, and the temperature is lowered to 25° C. after decolorization.
所述阴离子交换树脂柱加入氢氧化钠溶液进行再生。The anion exchange resin column is regenerated by adding sodium hydroxide solution.
实施例3Example 3
一种从果糖溶液中联产氨基葡萄糖盐酸盐和D-阿洛酮糖的方法,包括以下步骤:A method for co-producing glucosamine hydrochloride and D-psicose from a fructose solution comprises the following steps:
A:80g/L的果糖溶液(50.0L)中加入D-阿洛酮糖3-差向异构酶,然后加入浓度为80mmol/L的磷酸盐缓冲溶液(磷酸氢二钾的浓度为13.93g/L,磷酸二氢钾的浓度为1.09g/L)调节体系pH至7.5,在35℃下反应8h,得反应液(55.0L),其中所述D-阿洛酮糖3-差向异构酶的加入量为20U/mL;A: D-psicose 3-epimerase was added to 80 g/L fructose solution (50.0 L), and then 80 mmol/L phosphate buffer solution (the concentration of dipotassium hydrogen phosphate was 13.93 g/L, and the concentration of potassium dihydrogen phosphate was 1.09 g/L) was added to adjust the pH of the system to 7.5, and the mixture was reacted at 35° C. for 8 h to obtain a reaction solution (55.0 L), wherein the amount of D-psicose 3-epimerase added was 20 U/mL;
B:反应液以35mL/min的流速进中空纤维膜分离,实现酶和混合液(58.0L)的分离;B: The reaction solution was separated by hollow fiber membrane at a flow rate of 35 mL/min to achieve separation of enzyme and mixed solution (58.0 L);
C:向混合液中加入氨基葡萄糖-6-磷酸合成酶和氯化铵,混合均匀,然后加入浓度为80mmol/L的磷酸盐缓冲溶液(磷酸氢二钾的浓度为13.93g/L,磷酸二氢钾的浓度为1.09g/L)调节体系pH至7.0,在40℃下反应10h,得含氨基葡萄糖和D-阿洛酮糖的料液(68.0L),其中,所述氨基葡萄糖-6-磷酸合成酶的加入量为40U/mL,所述氯化铵的加入量占混合液体积的600mmol/L;C: Add glucosamine-6-phosphate synthase and ammonium chloride to the mixed solution, mix well, then add phosphate buffer solution with a concentration of 80 mmol/L (the concentration of dipotassium hydrogen phosphate is 13.93 g/L, and the concentration of potassium dihydrogen phosphate is 1.09 g/L) to adjust the pH of the system to 7.0, react at 40°C for 10 hours, and obtain a feed solution (68.0 L) containing glucosamine and D-psicose, wherein the amount of glucosamine-6-phosphate synthase added is 40 U/mL, and the amount of ammonium chloride added accounts for 600 mmol/L of the volume of the mixed solution;
D:将含氨基葡萄糖和阿洛酮糖的料液经陶瓷膜过滤,收集陶瓷膜清液(73.0L),所述陶瓷膜的孔径范围为80nm;D: filtering the slurry containing glucosamine and psicose through a ceramic membrane, and collecting the ceramic membrane clear liquid (73.0 L), wherein the pore size range of the ceramic membrane is 80 nm;
E:将陶瓷膜清液过超滤膜,收集超滤膜清液(78.0L),所述超滤膜的孔径范围为8000Da;E: passing the ceramic membrane clear liquid through an ultrafiltration membrane, and collecting the ultrafiltration membrane clear liquid (78.0 L), wherein the pore size range of the ultrafiltration membrane is 8000 Da;
F:将收集的超滤膜清液以3BV/h的流速进阳离子交换树脂柱,收集的第一流出液(109.5L)以1BV/h的流速进阴离子交换树脂柱,收集得到第二流出液(129.5L);F: The collected ultrafiltration membrane clear liquid is fed into a cation exchange resin column at a flow rate of 3 BV/h, and the collected first effluent (109.5 L) is fed into an anion exchange resin column at a flow rate of 1 BV/h to collect a second effluent (129.5 L);
G:将第二流出液经纳滤膜过滤,收集纳滤浓液(14.5L),所述纳滤膜的孔径范围为200Da,纳滤清液(125.0L)用于盐酸溶液和氢氧化钠溶液的配制;G: Filter the second effluent through a nanofiltration membrane, collect the nanofiltration concentrate (14.5 L), the pore size range of the nanofiltration membrane is 200 Da, and the nanofiltration clear liquid (125.0 L) is used for the preparation of hydrochloric acid solution and sodium hydroxide solution;
H:将纳滤浓液在温度60℃,真空度<-0.090Mpa的条件下浓缩至固含75%w/w,然后降温至12℃,抽滤,用乙醇进行洗涤,抽滤,得D-阿洛酮糖(1134g),收率为94.5,纯度为99.8%,晶体颜色为白色;H: The nanofiltrate concentrate was concentrated to a solid content of 75% w/w at a temperature of 60° C. and a vacuum degree of <-0.090 MPa, then cooled to 12° C., filtered, washed with ethanol, and filtered to obtain D-psicose (1134 g) with a yield of 94.5 and a purity of 99.8%. The crystal color was white;
I:然后用0.3mol/L的盐酸溶液以1.2BV/h的流速进步骤F中的阳离子交换树脂柱,盐酸溶液的进料量为阳离子交换树脂柱体积的2.5倍。收集pH小于2的流出液(15L),用于盐酸溶液的配制,收集pH 2-3的流出液(40.5L),浓缩至固含量为80%w/w,然后以3℃/h的速度降温至22℃,过滤后得到氨基葡萄糖盐酸盐粗品(2562g)。I: Then, 0.3 mol/L hydrochloric acid solution was fed into the cation exchange resin column in step F at a flow rate of 1.2 BV/h, and the feed amount of the hydrochloric acid solution was 2.5 times the volume of the cation exchange resin column. The effluent (15 L) with a pH value less than 2 was collected for the preparation of the hydrochloric acid solution, and the effluent (40.5 L) with a pH value of 2-3 was collected and concentrated to a solid content of 80% w/w, and then cooled to 22°C at a rate of 3°C/h, and filtered to obtain a crude product of glucosamine hydrochloride (2562 g).
将氨基葡萄糖盐酸盐粗品中加入纯水,进行搅拌,升温至粗品溶解(6.5L),加入活性炭进行脱色,然后降温,过滤,洗涤,干燥得到氨基葡萄糖磷酸盐成品(2421g),收率为94.5%,纯度为99.6%,晶体颜色为白色。Pure water was added to the crude glucosamine hydrochloride, stirred, and heated until the crude product was dissolved (6.5 L). Activated carbon was added for decolorization, and then cooled, filtered, washed, and dried to obtain the finished glucosamine phosphate (2421 g) with a yield of 94.5%, a purity of 99.6%, and white crystal color.
纯化水的加入量为氨基葡萄糖盐酸盐粗品重量的1倍,加入纯化水后的搅拌转速为100r/min,加热溶解温度为80℃;The amount of purified water added is 1 times the weight of the crude glucosamine hydrochloride. The stirring speed after adding purified water is 100 r/min, and the heating and dissolving temperature is 80°C.
所述活性炭的加入量占氨基葡萄糖盐酸盐粗品重量的3%w/w,脱色后降温至22℃。The amount of activated carbon added is 3% w/w of the weight of the crude glucosamine hydrochloride, and the temperature is lowered to 22° C. after decolorization.
所述阴离子交换树脂柱加入氢氧化钠溶液进行再生。The anion exchange resin column is regenerated by adding sodium hydroxide solution.
对比例1Comparative Example 1
一种从果糖溶液中生产D-阿洛酮糖的方法,包括以下步骤:A method for producing D-psicose from a fructose solution, comprising the following steps:
A:80g/L的果糖溶液(50.0L)中加入D-阿洛酮糖3-差向异构酶,然后加入浓度为80mmol/L的磷酸盐缓冲溶液(磷酸氢二钾的浓度为13.93g/L,磷酸二氢钾的浓度为1.09g/L)调节体系pH至7.5,在35℃下反应8h,得反应液(56.0L),其中所述D-阿洛酮糖3-差向异构酶的加入量为20U/mL;A: D-psicose 3-epimerase was added to 80 g/L fructose solution (50.0 L), and then 80 mmol/L phosphate buffer solution (the concentration of dipotassium hydrogen phosphate was 13.93 g/L, and the concentration of potassium dihydrogen phosphate was 1.09 g/L) was added to adjust the pH of the system to 7.5, and the mixture was reacted at 35° C. for 8 h to obtain a reaction solution (56.0 L), wherein the amount of D-psicose 3-epimerase added was 20 U/mL;
B:反应液以35mL/min的流速进中空纤维膜分离,实现酶和含D-阿洛酮糖料液(61.0L)的分离;B: The reaction solution was separated by a hollow fiber membrane at a flow rate of 35 mL/min to achieve separation of the enzyme and the D-psicose-containing liquid (61.0 L);
C:将含D-阿洛酮糖料液过超滤膜,收集超滤膜清液(71.0L),所述超滤膜的孔径范围为8000Da;C: Passing the D-psicose-containing liquid through an ultrafiltration membrane, and collecting the ultrafiltration membrane clear liquid (71.0 L), wherein the pore size range of the ultrafiltration membrane is 8000 Da;
D:将收集的超滤膜清液以1BV/h的流速进阴离子交换树脂柱,收集得到流出液(92.5L);D: The collected ultrafiltration membrane clear liquid was passed into an anion exchange resin column at a flow rate of 1 BV/h, and the effluent (92.5 L) was collected;
E:将流出液经纳滤膜过滤,收集纳滤浓液(11.6L),所述纳滤膜的孔径范围为200Da;E: Filter the effluent through a nanofiltration membrane with a pore size range of 200 Da to collect the nanofiltration concentrate (11.6 L);
F:将纳滤浓液在温度60℃,真空度<-0.090Mpa的条件下浓缩至固含75%w/w,然后降温至12℃,抽滤,用乙醇进行洗涤,抽滤,得D-阿洛酮糖(942g),收率为78.5%,纯度为99.0%,晶体颜色为白色。F: The nanofiltrate concentrate was concentrated to a solid content of 75% w/w at a temperature of 60° C. and a vacuum degree of <-0.090 MPa, then cooled to 12° C., filtered, washed with ethanol, and filtered to obtain D-psicose (942 g) with a yield of 78.5%, a purity of 99.0%, and white crystal color.
对比例2Comparative Example 2
一种从果糖溶液中生产氨基葡萄糖盐酸盐的方法,包括以下步骤:A method for producing glucosamine hydrochloride from a fructose solution comprises the following steps:
A:80g/L的果糖溶液(50L)中加入氨基葡萄糖-6-磷酸合成酶和氯化铵,混合均匀,然后加入浓度为80mmol/L的磷酸盐缓冲溶液(磷酸氢二钾的浓度为13.93g/L,磷酸二氢钾的浓度为1.09g/L)调节体系pH至7.0,在40℃下反应10h,得含氨基葡萄糖的料液(58.5L),其中,所述氨基葡萄糖-6-磷酸合成酶的加入量为40U/mL,所述氯化铵的加入量占混合液体积的600mmol/L;A: Add glucosamine-6-phosphate synthase and ammonium chloride to 80 g/L fructose solution (50 L), mix well, then add phosphate buffer solution with a concentration of 80 mmol/L (the concentration of dipotassium hydrogen phosphate is 13.93 g/L, and the concentration of potassium dihydrogen phosphate is 1.09 g/L) to adjust the pH of the system to 7.0, react at 40°C for 10 h, and obtain a glucosamine-containing liquid (58.5 L), wherein the amount of glucosamine-6-phosphate synthase added is 40 U/mL, and the amount of ammonium chloride added accounts for 600 mmol/L of the volume of the mixed solution;
D:将含氨基葡萄糖的料液经陶瓷膜过滤,收集陶瓷膜清液(69.0L),所述陶瓷膜的孔径范围为80nm;D: filtering the glucosamine-containing liquid through a ceramic membrane, collecting the ceramic membrane clear liquid (69.0 L), wherein the pore size range of the ceramic membrane is 80 nm;
E:将陶瓷膜清液过超滤膜,收集超滤膜清液(80.0L),所述超滤膜的孔径范围为8000Da;E: passing the ceramic membrane clear liquid through an ultrafiltration membrane, and collecting the ultrafiltration membrane clear liquid (80.0 L), wherein the pore size range of the ultrafiltration membrane is 8000 Da;
F:将收集的超滤膜清液以3BV/h的流速进阳离子交换树脂柱,收集得到流出液(102.5L);F: The collected ultrafiltration membrane clear liquid was passed into a cation exchange resin column at a flow rate of 3 BV/h, and the effluent (102.5 L) was collected;
G:将流出液经纳滤膜过滤,收集纳滤浓液(13.4L),所述纳滤膜的孔径范围为200Da;G: Filter the effluent through a nanofiltration membrane with a pore size range of 200 Da to collect the nanofiltration concentrate (13.4 L);
H:然后用0.3mol/L的盐酸溶液以1.2BV/h的流速进步骤F中的阳离子交换树脂柱,盐酸溶液的进料量为阳离子交换树脂柱体积的2.5倍。收集pH小于2的流出液(16.0L),用于盐酸溶液的配制,收集pH 2-3的流出液(45.0L),浓缩至固含量为80%w/w,然后以3℃/h的速度降温至22℃,过滤后得到氨基葡萄糖盐酸盐粗品(2310g)。H: Then, 0.3 mol/L hydrochloric acid solution was fed into the cation exchange resin column in step F at a flow rate of 1.2 BV/h, and the feed amount of the hydrochloric acid solution was 2.5 times the volume of the cation exchange resin column. The effluent (16.0 L) with a pH value less than 2 was collected for the preparation of the hydrochloric acid solution, and the effluent (45.0 L) with a pH value of 2-3 was collected and concentrated to a solid content of 80% w/w, and then cooled to 22°C at a rate of 3°C/h, and filtered to obtain a crude glucosamine hydrochloride product (2310 g).
将氨基葡萄糖盐酸盐粗品中加入纯水,进行搅拌,升温至粗品溶解(8.5L),加入活性炭进行脱色,然后降温,过滤,洗涤,干燥得到氨基葡萄糖磷酸盐成品(1767g),收率为76.5%,纯度为98.7%,晶体为白色。Pure water was added to the crude glucosamine hydrochloride, stirred, and heated until the crude product was dissolved (8.5 L). Activated carbon was added for decolorization, and then cooled, filtered, washed, and dried to obtain the finished glucosamine phosphate (1767 g) with a yield of 76.5%, a purity of 98.7%, and white crystals.
纯化水的加入量为氨基葡萄糖盐酸盐粗品重量的2倍,加入纯化水后的搅拌转速为100r/min,加热溶解温度为70℃;The amount of purified water added is twice the weight of the crude glucosamine hydrochloride. The stirring speed after adding purified water is 100 r/min, and the heating and dissolving temperature is 70°C.
所述活性炭的加入量占氨基葡萄糖盐酸盐粗品重量的3%w/w,脱色后降温至22℃。The amount of activated carbon added is 3% w/w of the weight of the crude glucosamine hydrochloride, and the temperature is lowered to 22° C. after decolorization.
所述阴离子交换树脂柱加入氢氧化钠溶液进行再生。The anion exchange resin column is regenerated by adding sodium hydroxide solution.
应理解,这些实施例仅用于说明本发明而不用于限制本发明的范围。此外应理解,在阅读了本发明讲授的内容之后,本领域技术人员可以对本发明作各种改动或修改,这些等价形式同样落于本申请所附权利要求书所限定的范围。It should be understood that these embodiments are only used to illustrate the present invention and are not used to limit the scope of the present invention. In addition, it should be understood that after reading the content taught by the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope limited by the appended claims of the application.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410505926.XA CN118389625A (en) | 2024-04-25 | 2024-04-25 | Method for co-producing glucosamine hydrochloride and D-psicose from fructose solution |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410505926.XA CN118389625A (en) | 2024-04-25 | 2024-04-25 | Method for co-producing glucosamine hydrochloride and D-psicose from fructose solution |
Publications (1)
Publication Number | Publication Date |
---|---|
CN118389625A true CN118389625A (en) | 2024-07-26 |
Family
ID=92006729
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410505926.XA Pending CN118389625A (en) | 2024-04-25 | 2024-04-25 | Method for co-producing glucosamine hydrochloride and D-psicose from fructose solution |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118389625A (en) |
-
2024
- 2024-04-25 CN CN202410505926.XA patent/CN118389625A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104450806B (en) | A kind of method that enzyme process prepares sodium gluconate | |
WO2018228246A1 (en) | Method for enzymatic preparation of glutathione | |
CN108822163B (en) | Comprehensive cyclic production method of D-glucosamine hydrochloride | |
CN102268490A (en) | Clean technique for co-producing xylose, xylitol and arabinose from agricultural and forestal waste | |
CN110028533A (en) | A kind of method and application of the refining amino glucosamine salt hydrochlorate from microbial fermentation solution | |
CN106188167B (en) | A method of separation and Extraction N- acetyl group-D- Glucosamine and D- Glucosamine from ammonia sugar fermentation liquid | |
CN110669081B (en) | A kind of method for preparing glucosamine sulfate | |
CN109735559B (en) | A kind of biological preparation method of gamma-aminobutyric acid | |
CN106831895A (en) | A kind of method of purifying N acetylglucosamines | |
CN108440624B (en) | Environment-friendly method for separating and purifying cytidine from microbial fermentation broth | |
CN108285913B (en) | Process for preparing and extracting L-glutamine | |
CN102690846A (en) | Method for catalytically synthesizing gamma-aminobutyric acid from glutamate biological solid-phase enzyme | |
CN111018926B (en) | Method for extracting high-purity glucosamine hydrochloride from glucosamine fermentation broth | |
CN113215210A (en) | Method for preparing sialic acid by adopting polysialic acid fermentation liquor | |
CN113005161B (en) | Preparation method of polysialic acid and polysialic acid product | |
CN113045610B (en) | Method for extracting glucosamine from N-acetylglucosamine fermentation liquor | |
WO2025055972A1 (en) | Method for synthesizing sucralose by enzymatic catalysis | |
CN118389625A (en) | Method for co-producing glucosamine hydrochloride and D-psicose from fructose solution | |
CN112851724B (en) | A kind of preparation method of vegetarian D-glucosamine hydrochloride | |
CN112662714B (en) | Production process for preparing ornithine | |
CN109321613B (en) | A kind of method for producing D-mannose | |
CN108220351B (en) | Method for preparing L-arginine-alpha-ketoglutaric acid by biological enzyme method | |
CN113980090A (en) | Method for recovering biological source protein by using biological medicine fermentation fungus residues | |
EP4406936A1 (en) | Method for producing tyrosine from fermented broth | |
CN102676598A (en) | Method for catalytically synthesizing gamma-aminobutyric acid by using sodium glutamate and immobilized bio-enzyme |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20241023 Address after: 224237 No. 18, Tonghai Avenue, Dongtai coastal economic zone, Yancheng City, Jiangsu Province Applicant after: DONGTAI HAORUI BIOLOGICAL TECHNOLOGY Co.,Ltd. Country or region after: China Address before: 262218 Xinxing Town, Zhucheng City, Weifang City, Shandong Province Applicant before: Zhucheng Haotian Biotechnology Co.,Ltd. Country or region before: China |
|
TA01 | Transfer of patent application right |